GlassScriptPhysician profile
Mohammed H Ahmed
NPI 1770593105
$7,391.37
in general payments reported to CMS, 2019-2025
31 companies · $483 in 2025
The $483 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,179 · 2020: $983 · 2021: $1,395 · 2022: $1,252 · 2023: $942 · 2024: $1,158 · 2025: $483.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,583.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,583.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,273.48 | 2020-2025 | Gallant, Assurity, Jot Dx |
| Biotronik INC. | $910.07 | 2019-2025 | Amvia Edge, Biomonitor, Selectra |
| Astrazeneca Pharmaceuticals LP | $454.74 | 2019-2023 | Farxiga |
| Akcea Therapeutics, INC. | $330.73 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $311.87 | 2019-2025 | Jardiance |
| Pfizer INC. | $303.13 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $274.00 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $225.20 | 2019-2021 | |
| Kyowa Kirin, INC. | $193.28 | 2020-2022 | |
| Bardy Diagnostics, INC. | $100.00 | 2019-2020 | |
| Livanova USA, INC. | $92.64 | 2020-2024 | Vns Therapy Symmetry Model 8103 Generator |
| Genzyme Corporation | $90.68 | 2023-2024 | |
| Amgen INC. | $88.18 | 2019-2020 | |
| Amarin Pharma, INC. | $86.47 | 2020 | |
| Avanir Pharmaceuticals, INC. | $82.62 | 2019-2020 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $82.46 | 2020-2021 | |
| Medtronic, INC. | $82.14 | 2021-2024 | Azure Xt Dr Mri Surescan, Venaseal |
| E.R. Squibb & Sons, L.L.C. | $72.05 | 2022-2025 | Camzyos |
| B. Braun Medical INC. | $63.78 | 2023 | Dialog+ |
| Novo Nordisk INC | $46.52 | 2021-2023 | Ozempic, Rybelsus |
| Nestle Healthcare Nutrition INC. | $27.08 | 2023 | |
| Lundbeck LLC | $26.77 | 2023 | Vyepti |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.28 | 2023 | Lifevest |
| Irhythm Technologies, INC. | $21.49 | 2019 | |
| Abbvie INC. | $20.73 | 2021 | |
| Philips North America LLC | $20.71 | 2021 | |
| Hikma Pharmaceuticals USA | $20.35 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.47 | 2022 | |
| Impulse Dynamics (USA) INC. | $16.73 | 2022 | |
| Edwards Lifesciences Corporation | $15.98 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Boston Scientific Corporation | $14.74 | 2024 | Watchman Flx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammed Ahmed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.